These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 6442001)

  • 1. The mechanism of action of nitroglycerin. Stenosis vasodilation as a major component of the drug response.
    Dodge HT; Brown BG
    Scand J Clin Lab Invest Suppl; 1984; 173():41-5. PubMed ID: 6442001
    [No Abstract]   [Full Text] [Related]  

  • 2. Different effects of nitroglycerin and nitroprusside on myocardial blood flow and metabolism.
    Ihlen H
    Scand J Clin Lab Invest Suppl; 1984; 173():75-9. PubMed ID: 6442005
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanism of action and clinical use of nitroglycerin.
    Horwitz LD
    Postgrad Med; 1973 Apr; 53(4):167-9. PubMed ID: 4632992
    [No Abstract]   [Full Text] [Related]  

  • 4. Variable responses of highly stenotic coronary arteries and collateral circulation to intracoronary injection of nitroglycerin in patients with chronic effort angina.
    Fujita M; Yamanishi K; Miwa K; Inoko M
    Coron Artery Dis; 1994 Jun; 5(6):525-9. PubMed ID: 7952412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitroglycerin--the first hundred years.
    Lancet; 1979 Dec 22-29; 2(8156-8157):1340-1. PubMed ID: 92679
    [No Abstract]   [Full Text] [Related]  

  • 6. Alpha adrenergic constriction of coronary arteries in conscious dogs.
    Vatner SF; Pagani M; Manders WT
    Trans Assoc Am Physicians; 1979; 92():229-38. PubMed ID: 232943
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of nitroglycerin on flow after partial constriction of the coronary artery.
    Malindzak GS; Green HD; Stagg PL
    J Appl Physiol; 1970 Jul; 29(1):17-22. PubMed ID: 4987498
    [No Abstract]   [Full Text] [Related]  

  • 8. Importance of maintaining systemic blood pressure during nitroglycerin administration for reducing ischemic injury in patients with coronary disease. Effects on coronary blood flow, myocardial energetics and left ventricular function.
    Miller RR; Awan NA; DeMaria AN; Amsterdam EA; Mason DT
    Am J Cardiol; 1977 Oct; 40(4):504-8. PubMed ID: 410286
    [No Abstract]   [Full Text] [Related]  

  • 9. Difference in site and time course of coronary dilating effects of trapidil, nitroglycerin and dipyridamole in anesthetized dogs.
    Noguchi K; Tomoike H; Ootsubo H; Sakai K; Nakamura M
    J Pharmacol Exp Ther; 1981 Dec; 219(3):809-14. PubMed ID: 6795344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous nitroglycerin for rest angina. Potential pathophysiologic mechanisms of action.
    DePace NL; Herling IM; Kotler MN; Hakki AH; Spielman SR; Segal BL
    Arch Intern Med; 1982 Oct; 142(10):1806-9. PubMed ID: 6812520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of nitrate-induced vasodilatation and tolerance on a biochemical base.
    Kukovetz WR; Holzmann S
    Z Kardiol; 1985; 74 Suppl 1():39-44. PubMed ID: 2986371
    [No Abstract]   [Full Text] [Related]  

  • 12. Alpha adrenergic vasoconstriction and nitroglycerin vasodilation of large coronary arteries in the conscious dog.
    Vatner SF; Pagani M; Manders WT; Pasipoularides AD
    J Clin Invest; 1980 Jan; 65(1):5-14. PubMed ID: 6765959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of nitroglycerin on the regional myocardial blood flow in man (author's transl)].
    Mösslacher H; Slany J; Imhof H; Umek H; Dorau F
    Wien Klin Wochenschr; 1974 Mar; 86(6):145-7. PubMed ID: 4216168
    [No Abstract]   [Full Text] [Related]  

  • 14. Relief of myocardial ischemia with nitroglycerin: what is the mechanism?
    Feldman RL; Conti CR
    Circulation; 1981 Dec; 64(6):1098-100. PubMed ID: 6794932
    [No Abstract]   [Full Text] [Related]  

  • 15. [Blood circulation and hemodynamics of heart in angina pectoris].
    Heinrich K; Steim H
    Med Klin; 1974 Nov; 69(47):1956-8. PubMed ID: 4216751
    [No Abstract]   [Full Text] [Related]  

  • 16. Organ protection: benefit from antihypertensive treatment?
    Motz W; Strauer BE
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S50-4. PubMed ID: 7898094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of nitroglycerin on the isolated blood-perfused dog heart.
    Gerlings ED; Gilmore JP
    Recent Adv Stud Cardiac Struct Metab; 1973; 3():419-27. PubMed ID: 4219818
    [No Abstract]   [Full Text] [Related]  

  • 18. [Long-term effects of nitroglycerin on the heart and peripheral vessels in patients with coronary disease during rest and in frequency-induced angina pectoris].
    Westermann KW; Langbehn AF; Kugler G
    Verh Dtsch Ges Kreislaufforsch; 1974; 40():458-61. PubMed ID: 4217505
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of angina pectoris. Therapeutic methods and physiologic mechanisms.
    Amsterdam EA; Hughes JL; Miller RR; Massumi RA; Zelis R; Mason DT
    Adv Cardiol; 1974; 11(00):175-90. PubMed ID: 4213235
    [No Abstract]   [Full Text] [Related]  

  • 20. Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition on coronary endothelial function.
    Wassmann S; Faul A; Hennen B; Scheller B; Böhm M; Nickenig G
    Circ Res; 2003 Oct; 93(9):e98-103. PubMed ID: 14551237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.